1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

X Med pphylx

Discussion in 'Pfizer' started by anonymous, Oct 15, 2019 at 2:51 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So IS team, ready for a what 20-30% loss in H1 share?
     

  2. anonymous

    anonymous Guest

    15% tops, Stop being a doomsdayer.